The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure
Open accessAbstract
BACKGROUND: Tests for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) based on reverse transcriptase polymerase chain reaction (RT-PCR) are being used to rule out infection among high-risk persons, such as exposed inpatients and health care workers. It is critical to understand how the predictive value of the test varies with time from exposure and symptom onset to avoid being falsely reassured by negative test results. OBJECTIVE: To estimate the false-negative rate by day since infection. DESIGN: Literature review and pooled analysis. SETTING: = 1330). PATIENTS: A mix of inpatients and outpatients with SARS-CoV-2 infection. MEASUREMENTS: A Bayesian hierarchical model was fitted to estimate the false-negative rate by day since exposure and symptom onset. RESULTS: Over the 4 days of infection before the typical time of symptom onset (day 5), the probability of a false-negative result in an infected person decreases from 100% (95% CI, 100% to 100%) on day 1 to 67% (CI, 27% to 94%) on day 4. On the day of symptom onset, the median false-negative rate was 38% (CI, 18% to 65%). This decreased to 20% (CI, 12% to 30%) on day 8 (3 days after symptom onset) then began to increase again, from 21% (CI, 13% to 31%) on day 9 to 66% (CI, 54% to 77%) on day 21. LIMITATION: Imprecise estimates due to heterogeneity in the design of studies on which results were based. CONCLUSION: Care must be taken in interpreting RT-PCR tests for SARS-CoV-2 infection-particularly early in the course of infection-when using these results as a basis for removing precautions intended to prevent onward transmission. If clinical suspicion is high, infection should not be ruled out on the basis of RT-PCR alone, and the clinical and epidemiologic situation should be carefully considered. PRIMARY FUNDING SOURCE: National Institute of Allergy and Infectious Diseases, Johns Hopkins Health System, and U.S. Centers for Disease Control and Prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Lauer, S. A., Grantz, K. H., Bi, Q., Jones, F. K., Zheng, Q., Meredith, H. R., Azman, A. S., Reich, N. G., & Lessler, J. (2020) · Annals of Internal Medicine · doi:10.7326/m20-0504 · Cited by 5,970
Self-citationAi, T., Yang, Z., Hou, H., Zhan, C., Chen, C., Lv, W., Tao, Q., Sun, Z., & Xia, L. (2020) · Radiology · doi:10.1148/radiol.2020200642 · Cited by 5,685
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607
Bi, Q., Wu, Y., Mei, S., Ye, C., Zou, X., Zhang, Z., Liu, X., Wei, L., Truelove, S. A., Zhang, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30287-5 · Cited by 1,958
Self-citationProfiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Guo, L., Ren, L., Yang, S., Xiao, M., Chang, D., Yang, F., Dela Cruz, C. S., Wang, Y., Wu, C., Xiao, Y., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa310 · Cited by 1,587
COVID-19: Protecting health-care workers
Lancet, T. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30644-9 · Cited by 1,247
Yang, Y., Yang, M., Shen, C., Wang, F., Yuan, J., Li, J., Zhang, M., Wang, Z., Xing, L., Wei, J., et al. (2020) · doi:10.1101/2020.02.11.20021493 · Cited by 836
Kim, E. S., Chin, B. S., Kang, C. K., Kim, N. J., Kang, Y. M., Choi, J.-P., Oh, D. H., Kim, J.-H., Koh, B., Kim, S. E., et al. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e142 · Cited by 299
Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020
Danis, K., Epaulard, O., Bénet, T., Gaymard, A., Campoy, S., Botelho-Nevers, E., Bouscambert-Duchamp, M., Spaccaferri, G., Ader, F., Mailles, A., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa424 · Cited by 232
Dynamics of viremia in early hepatitis C virus infection
Glynn, S. A., Wright, D. J., Kleinman, S. H., Hirschkorn, D., Tu, Y., Heldebrant, C., Smith, R., Giachetti, C., Gallarda, J., & Busch, M. P. (2005) · Transfusion · doi:10.1111/j.1537-2995.2005.04390.x · Cited by 217
Liu, L., Liu, W., Zheng, Y., Jiang, X., Kou, G., Ding, J., Wang, Q., Huang, Q., Ding, Y., Ni, W., et al. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.05.008 · Cited by 163
Liu, L., Liu, W., Zheng, Y., Jiang, X., Kou, G., Ding, J., Wang, Q., Huang, Q., Ding, Y., Ni, W., et al. (2020) · doi:10.1101/2020.03.06.20031856 · Cited by 159
Chin, E. T., Huynh, B. Q., Chapman, L. A. C., Murrill, M. T., Basu, S., & Lo, N. C. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1383 · Cited by 109
TESTING FOR TREATMENT DIFFERENCES WITH DROPOUTS PRESENT IN CLINICAL TRIALS - A COMPOSITE APPROACH
Shih, W. J., & Quan, H. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970615)16:11<1263::aid-sim550>3.0.co;2-m · Cited by 93
Estimating the early death toll of COVID-19 in the United StatesPreprint
Weinberger, D., Cohen, T., Crawford, F. W., Mostashari, F., Olson, D., Pitzer, V., Reich, N., Russi, M., Simonsen, L., Watkins, A. E., et al. (2020) · medRxiv · doi:10.1101/2020.04.15.20066431 · Cited by 74
Epidemiologie von SARS-CoV-2-Infektion und COVID-19
Salzberger, B., Buder, F., Lampl, B. M. J., Ehrenstein, B. P., Hitzenbichler, F., & Hanses, F. (2020) · Der Internist · doi:10.1007/s00108-020-00834-9 · Cited by 61
Vibrio cholerae O1 transmission in Bangladesh: insights from a nationally representative serosurvey
Azman, A. S., Lauer, S. A., Bhuiyan, T. R., Luquero, F. J., Leung, D. T., Hegde, S. T., Harris, J. B., Paul, K. K., Khaton, F., Ferdous, J., et al. (2020) · The Lancet Microbe · doi:10.1016/s2666-5247(20)30141-5 · Cited by 41
Self-citationOn the duration of the period between exposure to HIV and detectable infection
Konrad, B. P., Taylor, D., Conway, J. M., Ogilvie, G. S., & Coombs, D. (2017) · Epidemics · doi:10.1016/j.epidem.2017.03.002 · Cited by 32
Preoperative SARS-CoV-2 screening: Can it really rule out COVID-19?
Lother, S. (2020) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-020-01746-w · Cited by 26
Seroprävalenz und SARS-CoV-2-Testung in Gesundheitsberufen
Ziemssen, F., Bayyoud, T., Bartz‐Schmidt, K. U., Peter, A., & Ueffing, M. (2020) · Der Ophthalmologe · doi:10.1007/s00347-020-01158-7 · Cited by 7
Cited by
Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020) · JAMA · doi:10.1001/jama.2020.12839 · Cited by 4,609
Long COVID: major findings, mechanisms and recommendations
Davis, H. E., McCorkell, L., Vogel, J. M., & Topol, E. J. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00846-2 · Cited by 4,153
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101019 · Cited by 2,881
“Furthermore, the likelihood of false negatives increases after day 3 of symptom onset, when the false negative rate is 20%, reaching 66% by day 21[40].”
BackgroundRapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
Dinnes, J., Deeks, J. J., Adriano, A., Berhane, S., Davenport, C., Dittrich, S., Emperador, D., Takwoingi, Y., Cunningham, J., Beese, S., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013705 · Cited by 1,156
Buitrago-Garcia, D., Egli-Gany, D., Counotte, M. J., Hossmann, S., Imeri, H., Ipekci, A. M., Salanti, G., & Low, N. (2020) · PLOS Medicine · doi:10.1371/journal.pmed.1003346 · Cited by 1,000
Metadata
- Authors
- Kucirka, L. M., Lauer, S. A., Laeyendecker, O., Boon, D., & Lessler, J.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2020-08-18
- Volume
- 173
- Issue
- 4
- Pages
- 262-267
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W3024506939
- Cited by
- 1,414
- References
- 22
- FWCI
- 38.99
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.